Case study
Linking EHR and proprietary data for novel real-world research
Continuous glucose monitoring (CGM) has transformed diabetes care by delivering real-time insights into glycemic control. Yet while CGM data capture daily glucose trends, they often lack the clinical context needed to study long-term outcomes and comorbidities.
To bridge this gap, Dexcom partnered with Truveta to securely link its proprietary CGM data with longitudinal electronic health record (EHR) data by leveraging the underlying technology behind Truveta Live Link. The result: a first-of-its-kind integrated dataset that connects glucose patterns with diagnoses, medications, labs, and outcomes for more than 200,000 patients.
This linked dataset is already fueling R&D, regulatory, and HEOR teams at Dexcom—accelerating insights into kidney disease progression, risk stratification, real-world effectiveness of CGM therapy, and more.
Download the case study for insight into:
- The methods and governance used to securely link proprietary data with longitudinal EHR data.
- How data linkage can validate data integrity and create a scalable foundation for longitudinal or prospective research.
- Opportunities to generate new evidence and accelerate innovation across R&D, safety, HEOR, and unmet need.
- The transformative potential of linking device and clinical data to study real-world outcomes with speed and scale.
